PYC Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| SAN | Sanofi | Outperform |
16
|
94.33€ | 102.80€ | 15.55% | 9 | 117.78€B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.39k | ¥5.24k | 7.71% | 0 | ¥10.32T |
| MRNA | Moderna | Outperform |
16
|
$117.31 | $135.42 | 7.75% | 1 | $44.96B |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.20% | 0 | ¥6.48T |
| BIIB | Biogen | Outperform |
10
|
$221.50 | $299.62 | 30.25% | 13 | $32.25B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$150.47 | $245.24 | 44.55% | 7 | $19.03B |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$81.03 | $111.56 | 35.75% | 5 | $15.39B |
| SRPT | Sarepta Therapeutics | Outperform |
6
|
$131.82 | $158.66 | 25.55% | 6 | $12.51B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$39.08 | $55.60 | 53.53% | 3 | $5.76B |
| DYN | Dyne Therapeutics | Buy |
5
|
$26.00 | $28.13 | 40.38% | 0 | $2.27B |
| DCPH | Deciphera Pharmaceuticals | Outperform |
6
|
$25.36 | $23.40 | 0.95% | 4 | $2.09B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥4.42k | ¥8.34k | 46.96% | 0 | ¥297.90B |
| WVE | Wave Life Sciences | Outperform |
6
|
$5.62 | $9.21 | 140.21% | 3 | $687.45M |
| STOK | Stoke Therapeutics | Buy |
4
|
$11.48 | $19.33 | 74.22% | 3 | $604.59M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$2.88 | $6.34 | 90.28% | 0 | $535.96M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.47 | $10.21 | 94.11% | 7 | $471.75M |